Clinical trials for donor egg IVF
Clinical research is an important component of the Center’s mission. Our clinical and laboratory staffs have initiated several research studies to answer many clinical questions. These studies help expand the scientific knowledge base and provide new technology to patients. Our clinical findings have been published in national journals and have played a role in advancing new knowledge to other Reproductive Medicine practices throughout the country. We are able to conduct this research only through the cooperation of our patients who are willing to participate in these studies. We dedicate all this advanced reproduction knowledge to them.
Current Research Being Done at the Center
We currently have 3 exciting research projects taking place at the Center:
Eeva MERGE Study–MultiCenter Registry with Eeva (Early Embryo Viability Assessment Test)
The MultiCenter Registry with Eeva™ (MERGE) Research Study is currently recruiting patients at The Center for Advanced Reproductive Services, Farmington, CT.
Eeva: The Early Embryo Viability Assessment Test, is a test to be used by IVF laboratories to analyze early embryo development and to aid in the selection of the best embryo for transfer. At the heart of Eeva is software that was designed to assess critical differences in early embryo growth and determine an embryo’s viability and the potential for further development.
The Eeva Test was developed based on landmark research conducted at Stanford University1 which discovered that early embryo growth events can predict embryo development and reflect the underlying health of the embryo.
Auxogyn Inc. recently completed a multi-center clinical trial using Eeva with 54 patients and 758 embryos. The results from the trial supported that when embryologists used Eeva in conjunction with their traditional techniques they were able to correctly identify non-viable embryos 86% of the time vs. only 58% of the time without using Eeva2. The goal of the MERGE study is to record and evaluate the use of traditional embryo grading techniques combined with Eeva in the treatment of in vitro fertilization.
If you are interested in participating in this research study, please contact Dr. Evelyn Neuber, The Center for Advanced Reproductive Services, @ 860.679.4612 for more information. Eeva is an Investigational device. Limited by United States law to investigational use.
* * ** * * * * * **** * * * *
1. Wong et al. in Nature Biotechnology, 2010.
The Patients Voice in HIV/AIDS Clinical Trial Participation: What motivates the willingness of HIV infected people to take part in HIV/AIDS clinical trials?
Book (LAP LAMBERT Academic Publishing)
Call to step up the pace of TB-HIV collaborative activities — Weekly Blitz
Discovery by biomedical research of new and improved interventions can get into the bucket of implementation.